Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3442]
News [8052]
Articles [64]
Editorials [9]
Conferences [214]
elearning [49]
Primary and secondary resistance in colorectal cancer
Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012
Analysing changes in the pharmaceutical industry
Dr Siegfried Bialojan – Ernst and Young, Germany
Analysing changes in the pharmaceutical industry ( Dr Siegfried Bialojan – Ernst and Young, Germany )
21 May 2012
Economics of treating patients
Dr Richard Schilsky – University of Chicago, USA
Economics of treating patients ( Dr Richard Schilsky – University of Chicago, USA )
21 May 2012
New approaches to personalised medicine
Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012
Goals of the German Consortium for Translational Cancer Research
Dr Hubert Serve – University of Frankfurt, Germany
Goals of the German Consortium for Translational Cancer Research ( Dr Hubert Serve – University of Frankfurt, Germany )
18 May 2012
Recent developments in neoadjuvant therapy
Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
17 May 2012
Highlights and goals of IMPAKT 2012
Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Endocrine therapy and endocrine resistant breast cancer
Prof Mitch Dowsett – The Institute for Cancer Research, London, UK
Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )
17 May 2012
Overcoming drug resistance and targeting critical pathways
Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA
Overcoming drug resistance and targeting critical pathways ( Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA )
17 May 2012
Heterogeneity of tumours and the challenges of biomarker development
Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy
Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )
17 May 2012
Targeting the PI3K/mTOR pathway
Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA
Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )
17 May 2012
Use of metformin against breast cancer
Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation